Monday, June 13, 2011

Uh oh, FDA revises advisory for Zocor...

Over the weekend, Reuters reported that (see here) the FDA revised it's recommendations for simvastatin (Zocor) (see here). The recommendation is to limit the use of the highest dose, 80 mg, of simvastatin in patients due to an increased risk of myopathy (muscle injury). This comes after the FDA reviewed data from the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) and found that particularly in their first year, patients who started the high dose were at a significantly elevated risk for myopathy. This news should not be a surprise tothe Unicity Science Blog followers. We posted on this issue way back in February of 2009 (see here).

The question then becomes - what do we do with this information? Well, for starters, you can look to clinically proven alternatives such as Bios Life Slim for cholesterol management. Unicity International has done and
will continue to do clinical trials to evaluate the effectiveness of the product in terms of maintaing healthy cholesterol levels (for examples see here, here and here).

Second - if you are taking a statin medication - supplement with CoQ10. Cholesterol and CoQ10 share the same starting biosynthetic starting point. This may be a simple way to mitigate the muscle pains caused by statin medications. Lastly - get out and exercise.

Another simple, yet effective way to help your body improve its ability to metabolize fats is through exercise. Plus, you get the added benefits of improved cardiovascular activity, reduced stress and improved learning! Get started today!

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.